Atezolizumab in locally advanced or metastatic urothelial cancer: a pooled analysis from the Spanish patients of the IMvigor 210 cohort 2 and 211 studies

BACKGROUND: The studies IMvigor 210 cohort 2 and IMvigor211 evaluated the efficacy of atezolizumab in patients with locally advanced or metastatic urothelial cancer (mUC) upon progression to platinum-based chemotherapy worldwide. Yet, the real impact of this drug in specific geographical regions is...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Transl Oncol
Main Authors: Sotelo, M., Alonso-Gordoa, T., Gajate, P., Gallardo, E., Morales-Barrera, R., Pérez-Gracia, J. L., Puente, J., Sánchez, P., Castellano, D., Durán, I.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7979625/
https://ncbi.nlm.nih.gov/pubmed/32897497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12094-020-02482-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados